Scholars Central

Mini reviewPublished 30 Nov 2020

Mini Review: Heparin treatment in COVID-19: Where are we?

Authors: Rizzo M, Pezone I, Amicone M, Riccio E, Pisani A

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Coronavirus disease 2019 (COVID-19) is a severe acute respiratory syndrome with a high mortality rate; it is caused by SARS-CoV-2, a new virus of the Coronaviridae family that emerged in Wuhan, Hubei, China, in December 2019 and rapidly spread worldwide until declared by the World Health Organization a global pandemic on March 11th, 2020. The race for an effective drug to prevent or treat SARS-CoV-2 infection is the highest priority among health care providers, government officials, and the pharmaceutical industry. Despite scientific effort, no pharmacological intervention has proven definitively beneficial, and care is primarily supportive.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Asian Journal of Biomedical and Pharmaceutical Sciences.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalAsian Journal of Biomedical and Pharmaceutical Sciences
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Rizzo M”
  • BylineArticles whose byline prints “Pezone I”
  • BylineArticles whose byline prints “Amicone M”
  • BylineArticles whose byline prints “Riccio E”
  • BylineArticles whose byline prints “Pisani A”